RA CAPITAL MANAGEMENT, L.P.
Q1 2021 13F-HR Holdings
Net value change ($000)
-521,778
(-7.3%)
New positions
19
Sold out positions
19
Turnover %
31.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VOR | 479,314 | NEW |
| TIL | 122,159 | NEW |
| NVAX | 121,845 | 28.8% |
| AVIR | 107,208 | 47.8% |
| EWTX | 84,943 | NEW |
| BOLT | 78,271 | NEW |
| MCRB | 76,063 | NEW |
| DSGN | 65,380 | NEW |
| MGNX | 57,118 | 57.1% |
| CNTB | 55,337 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| ARVN | -311,937 | -100.0% |
| TGTX | -228,356 | -50.5% |
| NKTX | -160,138 | -46.5% |
| ASND | -151,813 | -15.5% |
| KROS | -132,263 | -100.0% |
| ChemoCentryx, Inc. | -113,513 | -38.4% |
| FIVE PRIME THERAPEUTICS, INC. | -72,891 | -100.0% |
| Inhibrx, Inc. | -70,193 | -100.0% |
| LEGN | -67,818 | -100.0% |
| Forma Therapeutics Holdings, Inc. | -62,001 | -19.7% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|